Endoluminal Suturing Devices Market

Endoluminal Suturing Devices Market Analysis and Forecast by Fact.MR

• The global endoluminal suturing devices market is estimated at US$ 82.5 million in 2025, forecast to expand at a CAGR of 8.6% to reach US$ 204.4 million by 2036.
• Endoluminal suturing devices include flexible suturing systems, endoscopic tissue approximation platforms, anchoring and fixation devices, and associated accessories used during gastrointestinal endoscopic procedures.
• Demand is shaped by growing adoption of endoscopic alternatives to surgical intervention for GI defect closure, anti reflux therapy, and bariatric surgery revision.

Summary of Endoluminal Suturing Devices Market

• Market Snapshot
  • In 2025, the global Endoluminal Suturing Devices Market was valued at approximately USD 82.5 million.
  • The market is estimated to reach USD 89.6 million in 2026 and is projected to attain USD 204.4 million by 2036.
  • The endoluminal suturing devices market is likely to expand at a CAGR of 8.6% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 114.9 million between 2026 and 2036.
  • Flexible Endoluminal Suturing Devices account for 48% of product type share in 2026.
  • India (12.2%) and China (11%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Growing adoption of endoscopic full thickness suturing as an alternative to surgical intervention for GI defect closure, fistula management, and perforation repair.
  • Expanding endoscopic bariatric revision procedures for patients with weight regain after primary bariatric surgery are creating new procedural demand.
  • Increasing gastroenterologist training in advanced therapeutic endoscopy is building the proceduralist base required to drive device adoption.
  • Expanding institutional procurement and infrastructure development across emerging economies is increasing demand.
  • Product innovation and technology advancement are broadening market access and application scope.
• Product and Segment View
  • Flexible Endoluminal Suturing Devices account for 48% of the product type segment in 2026, supported by established use and procurement patterns.
  • Gastrointestinal Procedures accounts for 52% of the application segment in 2026.
• Key segmentation includes:
  • Product Type: Flexible Endoluminal Suturing Devices, Endoscopic Suturing Systems, Tissue Approximation Devices, Anchoring and Fixation Devices, Suturing Accessories
  • Application: Gastrointestinal Procedures, GI Defect Closure, Anti Reflux Procedures, Bariatric Surgery Support
  • End Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
  • Technology: Endoscopic Suturing Technology, Robotic Assisted Suturing Technology, Full Thickness Suturing Technology, Clip Based Closure Technology
  • Formulation: Device Based Systems, Disposable Devices, Cartridge Based Systems, Hybrid Kits
  • Distribution Channel: Direct Sales, Medical Device Distributors, Online Sales
• These systems enable:
  • Full thickness tissue approximation through flexible endoscopic platforms without external surgical incision
  • GI defect and perforation closure enabling non surgical management of endoscopic complications
  • Endoscopic bariatric revision through tissue plication and outlet reduction for weight regain management
• Geography and Competitive Outlook
  • India leads growth at 12.2%, supported by expanding advanced endoscopy capacity, growing gastroenterology training programs, and increasing adoption of therapeutic endoscopic techniques.
  • China at 11.0% reflects rising endoscopic procedure volumes, hospital equipment modernization, and growing specialist training in interventional endoscopy.
  • Asia Pacific shows strong momentum with South Korea at 10.7% and Japan at 9.8%, driven by advanced endoscopy practice and early adoption of new endoluminal techniques.
  • Key companies include Medtronic Plc, Ethicon Endo Surgery (Johnson and Johnson), Apollo Endosurgery Inc., Richard Wolf GmbH, Karl Storz GmbH, and Olympus Corporation, Teleflex Corporation, Braun Melsungen, Terumo Corporation, Boston Scientific.
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The endoluminal suturing devices market is an emerging interventional endoscopy segment where growth depends on proceduralist training, clinical evidence accumulation, and reimbursement pathway development. The clinical value proposition is clear for specific indications like GI defect closure and bariatric revision, but market expansion requires scaling training beyond academic centers and establishing the outcome data needed to support broader adoption and reimbursement coverage.'

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Growing adoption of endoscopic full thickness suturing as an alternative to surgical intervention for GI defect closure, fistula management, and perforation repair.
• Expanding endoscopic bariatric revision procedures for patients with weight regain after primary bariatric surgery are creating new procedural demand.
• Increasing gastroenterologist training in advanced therapeutic endoscopy is building the proceduralist base required to drive device adoption.

Key Market Constraints

• Steep learning curve for endoluminal suturing techniques limits adoption to advanced endoscopy centers with sufficient procedure volume for skill development.
• High per procedure device cost relative to surgical alternatives restricts adoption in price sensitive healthcare systems.
• Limited long term outcome data for some endoluminal suturing indications constrains clinical guideline endorsement and payer reimbursement.

Key Opportunity Areas

• Robotic assisted endoscopic suturing platforms are reducing procedural difficulty and potentially expanding the proceduralist pool beyond advanced endoscopists.
• Growing obesity prevalence and bariatric surgery revision demand are creating a large addressable patient population for endoluminal interventions.
• Combination platforms integrating suturing with tissue resection and hemostasis capability are expanding single procedure clinical utility.

Segment-wise Analysis of the Endoluminal Suturing Devices Market

• Flexible Endoluminal Suturing Devices hold 48% of the respective segment in 2026.
• Gastrointestinal Procedures hold 52% of the respective segment in 2026.
• Hospitals hold 62% of the respective segment in 2026.

Which Product Type Segment Leads the Endoluminal Suturing Devices Market?

Flexible endoluminal suturing devices account for 48% of the product type segment in 2026. Full thickness suturing platforms designed for deployment through standard therapeutic endoscopes generate the highest product value through a combination of capital system and disposable cartridge revenue.

The segment benefits from clinical evidence supporting full thickness tissue approximation for GI defect closure, stent fixation, and bariatric revision applications. Apollo Endosurgery's OverStitch platform remains the leading product, with competitors developing alternative suturing approaches to expand the market.

Which Application Segment Leads the Endoluminal Suturing Devices Market?

Gastrointestinal procedures account for 52% of the application segment in 2026. GI defect closure, perforation management, fistula repair, and stent fixation represent the largest clinical demand for endoluminal suturing capability across gastroenterology and interventional endoscopy practice.

The segment is supported by the growing complexity of therapeutic endoscopic procedures that create clinical situations requiring tissue approximation. As endoscopic resection of large polyps and submucosal tumors becomes more common, the need for defect closure and complication management drives suturing device utilization.

Which End Use Segment Leads the Endoluminal Suturing Devices Market?

Hospitals account for 62% of the end use segment in 2026, reflecting the concentration of advanced therapeutic endoscopy in hospital based endoscopy units with the infrastructure and specialist staffing required for complex interventional procedures.

Ambulatory surgical centers are growing as endoscopic bariatric revision and simpler suturing applications shift toward outpatient settings. Specialty clinics contribute through focused gastroenterology and bariatric practices that generate sufficient procedure volume to support endoluminal suturing adoption.

Which Product Trend is Shaping the Next Phase of Growth in the Endoluminal Suturing Devices Market?

Robotic assisted endoscopic suturing platforms are emerging as the most anticipated technology development in the market. These systems aim to reduce the technical difficulty of endoluminal suturing by providing improved instrument control, visualization, and ergonomics through robotic assistance, potentially expanding the number of gastroenterologists capable of performing suturing procedures.

The shift toward robotic assistance reflects the fundamental challenge of endoluminal suturing adoption. Current manual suturing platforms require significant training and procedure volume to achieve consistent results. Robotic platforms that simplify the procedural workflow could accelerate adoption beyond high volume academic centers into community gastroenterology practice, significantly expanding the addressable market.

Regional Outlook Across Key Markets

• India leads growth at 12.2%, supported by expanding advanced endoscopy capacity, growing gastroenterology training programs, and increasing adoption of therapeutic endoscopic techniques.
• China at 11.0% reflects rising endoscopic procedure volumes, hospital equipment modernization, and growing specialist training in interventional endoscopy.
• Asia Pacific shows strong momentum with South Korea at 10.7% and Japan at 9.8%, driven by advanced endoscopy practice and early adoption of new endoluminal techniques.

CAGR Table

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Market Outlook for Endoluminal Suturing Devices in the United States

The U.S. endoluminal suturing devices market is projected to grow at a CAGR of 8.6% through 2036. Demand is supported by advanced endoscopy practice, bariatric revision demand, and clinical evidence accumulation.

• Advanced endoscopy centers drive adoption of full thickness suturing platforms.
• Bariatric revision procedures create growing procedural demand.
• Clinical evidence supports expanding reimbursement coverage for endoluminal suturing.

Endoluminal Suturing Devices Demand Trends in India

The India endoluminal suturing devices market is projected to grow at a CAGR of 12.2% through 2036. Growth is supported by expanding advanced endoscopy capacity and gastroenterology training.

• Advanced endoscopy capacity expansion creates new procedure capability.
• Gastroenterology training programs build the proceduralist base.
• Hospital infrastructure development supports therapeutic endoscopy adoption.

China Endoluminal Suturing Devices Market Growth Assessment

The China endoluminal suturing devices market is projected to grow at a CAGR of 11.0% through 2036. Growth reflects rising endoscopic procedure volumes and specialist training expansion.

• Rising endoscopic procedure volumes drive device adoption.
• Specialist training expansion builds proceduralist capacity.
• Hospital equipment modernization supports advanced endoscopy platforms.

Japan Endoluminal Suturing Devices Market Demand Analysis

The Japan endoluminal suturing devices market is projected to grow at a CAGR of 9.8% through 2036. Demand is shaped by advanced endoscopy practice and early technology adoption.

• Advanced endoscopy practice supports structured adoption of suturing platforms.
• Early technology adoption positions Japan as a lead market for new devices.
• Clinical research supports evidence generation for emerging indications.

Germany Endoluminal Suturing Devices Market Opportunity Outlook

The Germany endoluminal suturing devices market is projected to grow at a CAGR of 9.2% through 2036. Demand is supported by academic gastroenterology leadership and clinical research.

• Academic gastroenterology centers drive adoption and evidence generation.
• Clinical research supports expanded indication development.
• Hospital procurement standards support quality device adoption.

Competitive Benchmarking and Company Positioning

Endoluminal Suturing Devices Market Analysis By Company

• Medtronic Plc holds a leading position with approximately 24% share, supported by a broad product portfolio and established institutional relationships.
• Ethicon Endo Surgery (Johnson and Johnson), Apollo Endosurgery Inc., Richard Wolf GmbH participate meaningfully across specific categories and regional channels.
• Competition is shaped by product differentiation, regulatory approvals, institutional procurement, and geographic distribution.

The competitive landscape is moderately fragmented. Medtronic Plc leads through portfolio breadth and market presence. Ethicon Endo Surgery (Johnson and Johnson), Apollo Endosurgery Inc., Richard Wolf GmbH maintain relevance across specific niches. Strategic priorities include expanding product portfolios, strengthening distribution, and investing in next generation development.

Key Companies in the Endoluminal Suturing Devices Market

• Medtronic Plc, Ethicon Endo Surgery (Johnson and Johnson), Apollo Endosurgery Inc., Richard Wolf GmbH are among the leading players globally.
• Karl Storz GmbH, Olympus Corporation, Teleflex Corporation, Braun Melsungen, Terumo Corporation, Boston Scientific hold positions across specific segments and regional markets.

Recent Industry Developments

• Apollo Endosurgery Inc. : Market Leadership / Endoscopic Suturing Platform (2025)
  • Apollo Endosurgery continued to expand clinical adoption of its OverStitch endoscopic suturing system, supporting growing procedural volumes across GI defect closure, bariatric revision, and anti reflux applications.
• Olympus Corporation : Technology Investment / Therapeutic Endoscopy (2025)
  • Olympus continued investment in its therapeutic endoscopy platform, supporting development of tissue management solutions compatible with its endoscope systems for advanced interventional gastroenterology procedures.
• Boston Scientific : Product Development / Endoscopic Closure Devices (2025)
  • Boston Scientific advanced its endoscopic closure device portfolio, supporting growing demand for tissue approximation and defect management solutions across therapeutic endoscopy applications.

Leading Companies Shaping the Endoluminal Suturing Devices Market

• Medtronic Plc
• Ethicon Endo Surgery (Johnson and Johnson)
• Apollo Endosurgery Inc.
• Richard Wolf GmbH
• Karl Storz GmbH
• Olympus Corporation
• Teleflex Corporation
• Braun Melsungen
• Terumo Corporation
• Boston Scientific

Sources and Research References

• Apollo Endosurgery Inc. OverStitch endoscopic suturing system updates.
• Olympus Corporation. Therapeutic endoscopy platform development.
• American Society for Gastrointestinal Endoscopy. Endoluminal suturing practice guidelines.
• Society of American Gastrointestinal and Endoscopic Surgeons. Bariatric revision endoscopy recommendations.
• Primary interviews with interventional endoscopists, gastroenterologists, bariatric surgeons, hospital procurement officers, and device training specialists.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

• What is the current and future size of the endoluminal suturing devices market?
• How fast is the market expected to grow between 2026 and 2036?
• Which product type leads the market by 2026?
• Which application segment accounts for the highest demand?
• What factors are driving demand globally?
• How is robotic assisted suturing influencing the market?
• Why is India the fastest growing market?
• Which countries show the fastest growth through 2036?
• Who are the key companies?
• How does Fact.MR estimate the forecast?

Endoluminal Suturing Devices Market Definition

The endoluminal suturing devices market covers flexible endoluminal suturing devices, endoscopic suturing systems, tissue approximation devices, anchoring and fixation devices, and associated accessories used during gastrointestinal endoscopic procedures for defect closure, anti reflux therapy, bariatric revision, and tissue plication. It includes device based, disposable, cartridge, and hybrid formats used across hospitals, ambulatory surgical centers, and specialty clinics.

Endoluminal Suturing Devices Market Inclusions

• Global and regional market size and forecasts for 2026 to 2036 across product type, application, end use, technology, formulation, distribution channel, and region.
• Regional demand analysis based on endoscopic procedure volumes, advanced endoscopy training capacity, and gastroenterology infrastructure.
• Pricing analysis across suturing system, disposable component, and accessory categories.
• Competitive landscape including product portfolios, clinical evidence, and proceduralist training programs.

Endoluminal Suturing Devices Market Exclusions

• Conventional surgical suturing instruments used in open and laparoscopic surgery.
• Endoscopic clip devices not designed for full thickness tissue suturing.
• Diagnostic endoscopes and imaging equipment without therapeutic suturing function.
• Stapling and anastomotic devices used in surgical rather than endoscopic settings.

Endoluminal Suturing Devices Market Research Methodology

• The methodology combines secondary research, primary interviews, and forecast modelling.
• It draws on 100+ secondary sources and benchmarks 50+ company product portfolios.
• Market sizing covers 30+ countries through a demand side model, supported by top down validation.
• Key inputs include industry procurement data, regulatory frameworks, technology adoption rates, and product pricing trends.
• The model cross checks demand with shipment volumes, pricing trends, channel mix, and product launch timelines.
• Primary validation includes 25+ interviews across manufacturers, distributors, healthcare providers, and end users.
• Final estimates go through supply validation, trade flow checks, and sensitivity testing.